| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy does not adequately manage the risks and governance around the purchasing, sale and supply of medicines liable to misuse such as codeine linctus. |
Will no longer supply codeine linctus for sale over the counter for purchase |
18/12/2020 | 04/12/2020 |
| 1.2 | The pharmacy does not audit or monitor its purchases, sales and supplies of medicines liable to misuse such as codeine linctus, so it is unable to identify potential abuse and misuse. |
Will write up an updated SOP to identify and prevent the sale of medicines which are liable to abuse and misuse |
18/12/2020 | 22/12/2020 |
| 1.6 | The pharmacy does not have adequate systems in place to make sure its records about controlled drugs are always kept in line with statutory requirements. |
Will follow statutory requirements to maintain cd entries in a timely manner according to the law. Have employed extra staff to help with delegating tasks to maintain order in the pharmacy to help with this. |
18/12/2020 | 04/12/2020 |
| 4.3 | The pharmacy does not always supply medicines in line with their marketing authorisation. Re-packaging codeine linctus from stock bottles into smaller quantities means that the product was not sold or supplied in accordance with its marketing authorisation. |
Will no longer re-package codeine linctus from stock bottles into smaller quantities for supply |
18/12/2020 | 04/12/2020 |
| 4.2 | The pharmacy buys and sells large amounts of some medicines which may be liable to misuse or abuse such as codeine linctus without making appropriate checks. |
Have already stopped purchasing and selling codeine Linctus for over the counter sale. |
18/12/2020 | 04/12/2020 |
Pharmacy inspections
Inspection reports and learning from inspections